Medicinova (MNOV) Assets (2010 - 2026)
Medicinova (MNOV) posted quarterly Assets of $45.6 million for Q4 2025, down 18.39% year-over-year from $55.9 million in Q4 2024, and down 4.15% quarter-over-quarter from $47.6 million in Q3 2025.
Medicinova (MNOV) Assets (2010 - 2026) Analysis & Trends
Medicinova (MNOV) has reported Assets for 16 consecutive years, with $45.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Assets fell 18.39% year-over-year to $45.6 million; the TTM figure through Dec 2025 stood at $45.6 million (down 18.39% YoY), while the FY2025 annual figure was $45.6 million, down 18.39% from the prior year.
- Assets slipped to $45.6 million in Q4 2025 per MNOV's latest filing, from $47.6 million in the prior quarter.
- Across five years, Assets topped out at $96.1 million in Q1 2021 and bottomed at $45.6 million in Q4 2025.
- Historically, Assets has averaged $69.7 million across 5 years, with a median of $68.4 million in 2023.
- Annual changes were most pronounced in 2021 — Assets gained 24.78% — and 2025, when it slipped 18.39%.
- Medicinova's Assets stood at $87.4 million in 2021, then dropped by 15.16% to $74.2 million in 2022, then declined by 10.63% to $66.3 million in 2023, then declined by 15.68% to $55.9 million in 2024, then slipped by 18.39% to $45.6 million in 2025.
- Business Quant data shows MNOV's Assets at $45.6 million in Q4 2025, $47.6 million in Q3 2025, and $49.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Medicinova | 66.94 Mn | 66.94 Mn | 317,759.00 | 40.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.43 Mn |
| Dec 31, 2025 | 45.60 Mn |
| Sep 30, 2025 | 47.58 Mn |
| Jun 30, 2025 | 49.82 Mn |
| Mar 31, 2025 | 52.43 Mn |
| Dec 31, 2024 | 55.88 Mn |
| Sep 30, 2024 | 58.12 Mn |
| Jun 30, 2024 | 60.40 Mn |
| Mar 31, 2024 | 62.89 Mn |
| Dec 31, 2023 | 66.27 Mn |
| Sep 30, 2023 | 68.14 Mn |
| Jun 30, 2023 | 68.72 Mn |
| Mar 31, 2023 | 71.13 Mn |
| Dec 31, 2022 | 74.15 Mn |
| Sep 30, 2022 | 78.39 Mn |
| Jun 30, 2022 | 81.24 Mn |
| Mar 31, 2022 | 84.18 Mn |
| Dec 31, 2021 | 87.41 Mn |
| Sep 30, 2021 | 91.62 Mn |
| Jun 30, 2021 | 93.68 Mn |